Neogenomics (NEO) PT Lowered to $18 at Piper Sandler
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $16.66 +4.78%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Piper Sandler analyst David Westenberg lowered the price target on Neogenomics (NASDAQ: NEO) to $18.00 (from $21.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
- Palo Alto Networks (PANW) PT Raised to $390 at UBS, Neutral Rating Maintained
- Keysight Technologies (KEYS) PT Raised to $440 at UBS Amid Broad-Based AI Strength
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
